These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35121400)

  • 1. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
    Yu W; Ping Cheng L; Pang W; Ling Guo L
    Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel acylhydrazone neuraminidase inhibitors.
    Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
    Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
    Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
    Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
    Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel polyheterocyclic neuraminidase inhibitors with 1,3,4-oxadiazole thioetheramide as core backbone.
    Shang LL; Zhong ZJ; Cheng LP
    Eur J Med Chem; 2024 Apr; 269():116305. PubMed ID: 38518525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
    Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
    Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
    Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors.
    Zhong ZJ; Cheng LP; Pang W; Zheng XS; Fu SK
    Bioorg Med Chem Lett; 2021 Apr; 37():127839. PubMed ID: 33556571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of 1,3,4-triazole-3-acetamide derivatives as potent neuraminidase inhibitors.
    Shi L; Zhang XY; Cheng LP
    Bioorg Med Chem Lett; 2022 Apr; 61():128590. PubMed ID: 35108623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
    Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors.
    Fu SK; Cheng LP
    Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
    Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors.
    Cheng LP; Zhang XY; Pang W; Xiao XZ
    Future Med Chem; 2024; 16(12):1205-1218. PubMed ID: 38989986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifunctional Inhibitors of Influenza Virus Neuraminidase: Molecular Design of a Sulfonamide Linker.
    Evteev S; Nilov D; Polenova A; Švedas V
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
    Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
    Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
    Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
    Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
    Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.
    Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.